West Pharmaceutical Services, Inc.
WST
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $23.9B
$339.97
▼ -0.81%
P/E
43.36
Mkt Cap
$23.9B
52-Wk Range
$223.83–$386.00
52-Week Range
$223.83 - $386.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 34.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary polymer and packaging technologies
- Global manufacturing and distribution network
- Deep regulatory compliance expertise
- Long-standing pharmaceutical industry relationships
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Increasing global biologics market
Value
Significant premium - growth priced in
Momentum
Strong
+6.3% over 3m
Quality
Stable
Excellent business quality
Dividend
Token
0.26% yield
Smart-money signal
Who's buying WST right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 22, 2026
JUL 23, 2026
Reported EPS of $2.37 vs $2.08 consensus (+13.9% surprise). Revenue of $872.3M vs $840.0M expected (+3.9%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+13.9%
Revenue trend · last 8Q
—
+2%
+0%
+9%
+8%
+8%
+21%
+14%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$746.9M
$748.5M
$698.2M
$766.2M
$804.3M
$805.0M
$844.9M
$872.3M
Margins · last 8Q
Gross
37.7%
Operating
20.5%
Profit
17.6%
Wall Street consensus
7 analysts · 86% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
86%
Hold
14%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 3, 2026
vs Industry
How WST stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related